Prior to screening in both Jurkat and breast cancer cells, two assays were used to characterize their interaction with CXCR4: (i) CXCL12 induced calcium flux; and (ii) the HIV-1IIIB MAGI entry assay (Table 1). Here, CXCL12 is linked to breast cancer.